Virtual reality (VR) has emerged as a tool to treat chronic pain and is gaining popularity because it has fewer side-effects than surgery and most drugs, headsets have gone down in price, and graphics have improved to enable a more immersive experience.
In November, AppliedVR received the first authorization from the U.S. Food and Drug Administration to market a VR app for chronic lower-back pain, RelieVRx.
The system features what Stanford University's Beth Darnall, AppliedVR's chief science adviser, calls a "breath-fed tree," which provides the user a visual way to "reflect back to the user the changes that are occurring in their own physiology."
Researchers at AppliedVR reported an almost 43% decrease in chronic back pain among study participants who used RelieVRx, versus 25% for a control group.
From The New York Times Magazine
View Full Article - May Require Paid Subscription
Abstracts Copyright © 2022 SmithBucklin, Washington, DC, USA
No entries found